Company intelligence / Profile preview

MIDI Labs

Newark, Delaware, United States

Ownership: Private
Development stage: Other

Overview

MIDI Labs is an ISO 17025:2017 accredited, FDA-registered and USDA-permitted contract testing laboratory specializing in DNA sequencing and other methods for microbial identification and enumeration for pharmaceutical, probiotic, food, beverage, and personal care manufacturers. It was acquired by Biolog in January 2023 and now operates as the lab services division of Biolog, Inc.[1][2].

Industry: Molecular Diagnostics

Partnerships

Biolog (acquirer and technology partner)[1][2]

Beyond the preview

Go deeper on MIDI Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MIDI Labs.

Explore the full profile